Dr. Allen C. Wegener, M.D.
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- University of Mississippi School of Medicine (1991)
- Years since graduation
- 35
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 425
Licensed in Texas since 1992, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1991Medical school: University of Mississippi School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
TX license J2410 (first issued 1992; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Christus Mother Frances Hospital Tyler, TX
- Christus Good Shepherd Medical Center Longview, TX
- Christus Mother Frances Hospital- Jacksonville Jacksonville, TX
Medical groups
- Christus Trinity Clinic Texas (1,540 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 425
- Services billed
- 945
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 232 | 190 |
| Established patient office or other outpatient visit, 30-39 minutes | 166 | 132 |
| Diagnostic exam of bladder and urethra using an endoscope | 126 | 88 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 41 | 35 |
| New patient office or other outpatient visit, 45-59 minutes | 39 | 39 |
| Creation of sling around urethra in female to control leakage | 34 | 34 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 32 | 31 |
| Imaging of urinary tract following injection of a contrast agent | 29 | 27 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 22 | 17 |
| Insertion of stent in ureter using an endoscope | 21 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Tyler, TX | 465 |
| Myrbetriq (mirabegron) Other prescribers in Tyler, TX | 310 |
| Cephalexin Other prescribers in Tyler, TX | 258 |
| Finasteride Other prescribers in Tyler, TX | 177 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Tyler, TX | 168 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Tyler, TX | 166 |
| Solifenacin Succinate Other prescribers in Tyler, TX | 78 |
| Ciprofloxacin Hcl Other prescribers in Tyler, TX | 72 |
| Gemtesa (vibegron) Other prescribers in Tyler, TX | 61 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Tyler, TX | 36 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 11 payments worth $676 in total to this clinician.
| Boston Scientific Corporation | $222 |
|---|---|
| GE Healthcare | $162 |
| Janssen Biotech, Inc. | $136 |
| Dendreon Pharmaceuticals LLC | $92.45 |
| AstraZeneca Pharmaceuticals LP | $35.06 |
| Urogen Pharma, Inc. | $28.23 |
| Food and Beverage | $641 |
|---|---|
| Education | $35.06 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $35.06 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.